A federal judge has ruled that Delaware’s lawsuit against drug manufacturers, distributors and drugstores over the opioid crisis should be sent back to state court.
In a ruling last week, the judge granted the state’s request to remand the case back to Superior Court.
State officials filed the lawsuit in January, accusing pharmaceutical companies of misleading doctors and consumers about the risks and addictive qualities of prescription painkillers.
Named as defendants in the suit were manufacturers Purdue Pharma and Endo Pharmaceuticals, and drug distributors such as Cardinal Health and McKesson Corporation.
McKesson filed court papers to transfer the case to federal court, saying it involved issues regarding the Federal Controlled Substances Act.
But the judge said McKesson had failed to show that Delaware’s state law claims implicate federal jurisdiction.
Was this article valuable?
Here are more articles you may enjoy.
Florida’s Commercial Clearinghouse Bill Stirring Up Concerns for Brokers, Regulators 
Florida Engineers: Winds Under 110 mph Simply Do Not Damage Concrete Tiles 
Trump Demands $1 Billion From Harvard as Prolonged Standoff Appears to Deepen 
Florida Insurance Costs 14.5% Lower Than Without Reforms, Report Finds 
